Reversal of phencyclidine-induced hyperactivity by glycine and the glycine uptake inhibitor glycyldodecylamide

Neuropsychopharmacology

Volumn 17, Issue 3, 1997, Pages 202-204

  Javitt, Daniel C ^a   Sershen, Henry ^a   Hashim, Audrey ^a   Lajtha, Abel ^a  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Drug abuse; Excitatory amino acids; Negative symptoms; NMDA receptors; Rodent; Schizophrenia

Indexed keywords

AMPHETAMINE; GLYCINE; GLYCINE DERIVATIVE; GLYCYLDODECYLAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; PHENCYCLIDINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; CONTROLLED STUDY; HYPERACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT SURVEY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030811293     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00047-X     Document Type: Article

References (10)

1. D'Souza DC, Charney D, Krystal J (1995): Glycine site agonists of the NMDA receptor: a review. CNS Drug Rev 1:227-260
2. Goff DC, Tsai G, Manoach DS, Coyle JT (1995): Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am J Psychiatry 152:1213-1215
3. Heresco-Levy U, Silipo G, Javitt DC (1996): Glycinergic augmentation of NMDA receptor-mediated neurotransmission in the treatment of schizophrenia. Psychopharmacol Bull 32:731-740
4. Javitt DC, Frusciante M (1997): Glycyldodecylamide, a phencyclidine behavioral antagonist, blocks cortical glycine uptake: Implications for schizophrenia and substance abuse. Psychopharmacol 129:96-98
5. Javitt DC, Zukin SR (1991): Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148: 1301-1308
6. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MBJ, Charney DS (1994): Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199-214
7. Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995): Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13:9-19
8. Smith KE, Bordon LA, Hartig PR, Branchek T, Weinshank RL (1992): Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors. Neuron 8:927-935
9. Toth E, Lajtha A (1986): Antagonism of phencyclidine-induced hyperactivity by glycine in mice. Neurochem Res 11:393-400
10. Toth E, Weiss B, Banay-Schwartz M, Lajtha A (1986): Effect of glycine derivatives on behavioral changes induced by 3-mercaptopropionic acid or phencyclidine in mice. Res Comm Psychol Psychiat Behav 11:1-9